Hippocampal Sparing Whole Brain Radiation Versus Stereotactic Radiation in Patients With 5-20 Brain Metastases: A Phase III, Randomized Trial
Clinical trial NCT03075072 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03075072
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-10
- Primary completion
- 2024-11-07
- Enrollment
- 196
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.